The rollout comes weeks after the UAE became the first country outside the US to receive the oral version of the obesity treatment, giving eligible patients a needle-free option for chronic weight management
Research shows clear benefits: Better stability than oral delivery, which exposes peptides to harsh stomach conditions Less breakdown by enzymes that would destroy the peptide before it reaches the blood Easier compliance no needles, no mixing, just spray Potential for targeted delivery to specific tissues, including the brain via the olfactory pathway Nasal delivery works very well for peptides like BPC-157 that target the whole body
A joint statement from the Pharmacy and Medical Boards confirms that doctors have responsibilities to assess whether a compounded medicine is safe and appropriate for a patient
After glycocalyx degradation, the barrier function of endothelial cells is impaired, further aggravating systemic microcirculatory disorders and organ hypoperfusion [66,67,68]
For many people, diet and exercise simply arent enough to overcome the several factors that can complicate the weight loss process, including your metabolic makeup
We recommend 8 weeks on, followed by 4 weeks off before starting another cycle if needed
